Eastman Chemical Company is an American company primarily involved in the chemical industry. Once a subsidiary of Kodak, today it is an independent global specialty materials company that produces a broad range of advanced materials, chemicals and fibers for everyday purposes. The company is headquartered in Kingsport, Tennessee.
| Revenue (TTM) | $9.05B |
| Gross Profit (TTM) | $1.84B |
| EBITDA | $1.50B |
| Operating Margin | 13.20% |
| Return on Equity | 10.30% |
| Return on Assets | 3.99% |
| Revenue/Share (TTM) | $79.19 |
| Book Value | $54.89 |
| Price-to-Book | 1.20 |
| Price-to-Sales (TTM) | 0.81 |
| EV/Revenue | 1.322 |
| EV/EBITDA | 8.52 |
| Quarterly Earnings Growth (YoY) | 265.00% |
| Quarterly Revenue Growth (YoY) | 8.30% |
| Shares Outstanding | $114.33M |
| Float | $113.26M |
| % Insiders | 0.93% |
| % Institutions | 94.69% |
Volatility is currently expanding
Review Eastman Chemical's (EMN) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Eastman Chemical NYSE: EMN executives highlighted a reinstated U.S. Department of Energy grant, plans to expand circular-economy capacity and expectations for volume and cash-flow improvement in 2027 during the company's third-quarter 2026 earnings call.
Eastman Chemical Company ( EMN ) Q3 2026 Earnings Call October 30, 2026 8:00 AM EDT Company Participants Greg Riddle - Vice President of Investor Relations & Communications Mark Costa - Chairman & CEO William McLain - CFO & Executive VP Conference Call Participants Vincent Andrews - Morgan Stanley, Research Division Patrick Cunningham - Citigroup Inc., Research Division Joshua Spector - UBS Investment Bank, Research Division Frank Mitsch - Fermium Research, LLC John Ezekiel Roberts - Mizuho Securities USA LLC, Research Division Salvator Tiano - KeyBanc Capital Markets Inc., Research Division Ryan Weiss Jeffrey Zekauskas - JPMorgan Chase & Co, Research Division David Begleiter - Deutsche Bank AG, Research Division Matthew DeYoe - BofA Securities, Research Division Abigail Eberts - Wells Fargo Securities, LLC, Research Division Kevin Estok - Jefferies LLC, Research Division Kevin McCarthy - Vertical Research Partners, LLC Arun Viswanathan - RBC Capital Markets, Research Division Presentation Operator Good day, everyone, and welcome to the Third Quarter 2026 Eastman Conference Call. Today's conference is being recorded.
EMN's Q3 earnings missed estimates despite higher pricing, as improved margins and asset utilization boosted profitability across key segments.
Eastman Chemical (EMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rose's Income Garden portfolio review highlights 15 most undervalued and 15 most overvalued dividend stocks using 52-week high/low analysis. Energy names like XOM, SHEL, and CVX have rotated into overvalued territory, while high-yield REITs such as VICI remain top undervalued picks. Dividend yield remains a key selection criterion, with several undervalued stocks offering yields above 5% and investment-grade credit ratings.
Eastman Chemical Company is reiterated as a 'Buy' with a fair value of $104/share and a price target of $84/share. EMN's operational improvements, including 2Q26 AEPS up 23% and EBIT up 16%, contrast with market pessimism and a depressed 7-8x P/E multiple. The investment thesis centers on cost savings, volume recovery, and molecular recycling, supporting normalized EPS potential of $8/share.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on EMN and any ticker you trade — then tracks every position and per-strategy win rate.
